Related content

Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an α-internexin immunohistochemical study

By Armstrong R. A.   Cairns N. J.  

Journal of Neural Transmission, Vol. 114, Iss. 4, 2007-04 ,pp. : 451-456

Springer Publishing Company

Access to resources Recommend Favorite

α-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases

By Cairns Nigel   Uryu Kunihiro   Bigio Eileen   Mackenzie Ian   Gearing Marla   Duyckaerts Charles   Yokoo Hideaki   Nakazato Yoichi   Jaros Evelyn   Perry Robert   Arnold Steven   Lee Virginia   Trojanowski John  

Acta Neuropathologica, Vol. 108, Iss. 3, 2004-09 ,pp. : 213-223

Springer Publishing Company

Access to resources Recommend Favorite

Neurofilament inclusion body disease: a new proteinopathy?

By Rosa P.  

Brain, Vol. 126, Iss. 10, 2003-10 ,pp. : 2291-2303

Oxford University Press

Access to resources Recommend Favorite

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease

By Pountney D.L.   Huang Y.   Burns R.J.   Haan E.   Thompson P.D.   Blumbergs P.C.   Gai W.P.  

Experimental Neurology, Vol. 184, Iss. 1, 2003-11 ,pp. : 436-446

Elsevier

Access to resources Recommend Favorite

Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington’s, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease

By Mori Fumiaki   Tanji Kunikazu   Toyoshima Yasuko   Yoshida Mari   Kakita Akiyoshi   Takahashi Hitoshi   Wakabayashi Koichi  

Acta Neuropathologica, Vol. 123, Iss. 5, 2012-05 ,pp. : 747-749

Springer Publishing Company

Access to resources Recommend Favorite